Domain truncation, point mutation, and surrogation for structure based kinase inhibitor design

D Bossemeyer , C B Breitenlechner , M Gassel , R A Engh
Cellular & Molecular Biology Letters 10

2005
Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients.

F X Gruber , T Ernst , K Porkka , R A Engh
Leukemia 26 ( 1) 172 -177

34
2012
Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.

Alexander Pflug , Jevgenia Rogozina , Darja Lavogina , Erki Enkvist
Journal of Molecular Biology 403 ( 1) 66 -77

22
2010
Probing the ATP-Binding Pocket of Protein Kinase Dyrk1A with Benzothiazole Fragment Molecules

Ulli Rothweiler , Wenche Stensen , Bjørn Olav Brandsdal , Johan Isaksson
Journal of Medicinal Chemistry 59 ( 21) 9814 -9824

14
2016
Bifunctional Ligands for Inhibition of Tight-Binding Protein–Protein Interactions

Taavi Ivan , Erki Enkvist , Birgit Viira , Ganesh babu Manoharan
Bioconjugate Chemistry 27 ( 8) 1900 -1910

11
2016
Biofocussed chemoprospecting: An efficient approach for drug discovery

Balmukund Sureshkumar Thakkar , Marte Albrigtsen , John Sigurd Svendsen , Jeanette H Andersen
Chemical Biology & Drug Design 90 ( 1) 128 -140

1
2017
Novel scaffolds for Dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) inhibitors

Anna Czarna , Jinhua Wang , Diana Zelencova , Yao Liu
Journal of Medicinal Chemistry acs.jmedchem.7b01847

2018
Novel DYRK1A inhibitor rescues learning and memory deficits in a mouse model of down syndrome

Wenche Stensen , Ulli Rothweiler , Richard Alan Engh , Melissa R Stasko
Pharmaceuticals 14 ( 11) 1170 -1170

9
2021
Ultrafast dynamics of tryptophan: simulation and experiment

Richard Alan Engh
The University of Chicago

1987
Tryptophan Structure and Dynamics Using GROMOS

RICHARD A. ENGH , LIN X. CHEN , GRAHAM R. FLEMING
Annals of the New York Academy of Sciences 482 ( 1) 304 -306

1986
THE STRUCTURE OF CYSTATINS AND THEIR INTERACTIONS WITH COGNATE CYSTEINE PROTEINASES

W BODE , M STUBBS , D MUSIL , B LABER
JOURNAL OF CELLULAR BIOCHEMISTRY 123 -123

1994
The Three-Dimensional Structure of<* 1 AT

RICHARD A ENGH , WOLFRAM BODE
Alpha 1-Antitrypsin Deficiency: Biology-Pathogenesis-Clinical Manifestations-Therapy 77 -77

2014
PRODUCTION AND CHARACTERIZATION OF DELETION AND SUBSTITUTION MUTANTS OF CYSTATINS AS WELL AS OF CYSTATIN DIMERS

EA AUERSWALD , DK NAGLER , M BERND , W MACHLEIDT
JOURNAL OF CELLULAR BIOCHEMISTRY 150 -150

1994
Antitumoral and mechanistic studies of ianthelline isolated from the Arctic sponge Stryphnus fortis.

Trine Stiberg , Jeanette H. Andersen , Anne-Marie GENEVIèRE , Richard A. Engh
Anticancer Research 32 ( 10) 4287 -4297

15
2012
Dynamics simulation studies of apoazurin of Alcaligenes denitrificans

Lin X. Q. Chen , Richard A. Engh , Axel T. Bruenger , Dzung T. Nguyen
Biochemistry 27 ( 18) 6908 -6921

17
1988
The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine.

Marina Alexeeva , Espen Åberg , Richard A. Engh , Ulli Rothweiler
Acta Crystallographica Section D-biological Crystallography 71 ( 5) 1207 -1215

14
2015
X-ray Structure of Active Site-inhibited Clotting Factor Xa IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION

Hans Brandstetter , Anja Kühne , Wolfram Bode , Robert Huber
Journal of Biological Chemistry 271 ( 47) 29988 -29992

234
1996
Structural aspects of serpin inhibition.

Andreas J. Schulze , Robert Huber , Wolfram Bode , Richard A. Engh
FEBS Letters 344 117 -124

56
1994
Structure of leech derived tryptase inhibitor (LDTI-C) in solution

Peter Mühlhahn , Michael Czisch , Robert Morenweiser , Bianca Habermann
FEBS Letters 355 ( 3) 290 -296

38
1994